MarketCap
Facebook
X
TelegramCantel Medical Corp. Revenue 2011-2026 | CMD
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue Cantel Medical Corp.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 1.02 B | 918 M | 872 M | 770 M | 665 M | 565 M | 489 M | 425 M | 386 M | 322 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.02 B | 322 M | 643 M |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Medical instruments industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
169 M | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
2.75 B | $ 19.94 | 1.45 % | $ 10.2 B | USA |
 |
Luminex Corporation
LMNX
|
417 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
1.58 M | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
150 M | - | - | $ 955 M | USA |
 |
CRH Medical Corporation
CRHM
|
106 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
2.88 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
3.17 B | - | -0.02 % | $ 16.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
17.9 M | $ 8.05 | -2.07 % | $ 162 M | USA |
 |
Alcon
ALC
|
9.91 B | $ 80.14 | 1.44 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
465 M | $ 37.41 | 2.77 % | $ 1.76 B | USA |
 |
electroCore
ECOR
|
16 M | $ 6.53 | 3.82 % | $ 36 K | USA |
 |
ICU Medical
ICUI
|
2.38 B | $ 148.7 | 0.28 % | $ 3.63 B | USA |
 |
AngioDynamics
ANGO
|
292 M | $ 10.21 | 1.37 % | $ 417 M | USA |
 |
InfuSystem Holdings
INFU
|
110 M | $ 8.74 | 2.7 % | $ 180 M | USA |
 |
The Cooper Companies
COO
|
4.09 B | $ 81.74 | 0.05 % | $ 16.3 B | USA |
 |
Haemonetics Corporation
HAE
|
1.36 B | $ 76.43 | -3.0 % | $ 3.85 B | USA |
 |
Harvard Bioscience
HBIO
|
112 M | $ 0.57 | -2.96 % | $ 24.2 M | USA |
 |
Glaukos Corporation
GKOS
|
315 M | $ 103.94 | -5.75 % | $ 5.03 B | USA |
 |
Repro Med Systems
KRMD
|
28.5 M | $ 5.56 | -3.81 % | $ 254 M | USA |
 |
Isoray
ISR
|
3.55 M | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
592 M | $ 163.14 | 4.95 % | $ 5.09 B | USA |
 |
LeMaitre Vascular
LMAT
|
220 M | $ 85.13 | 2.15 % | $ 1.91 B | USA |
 |
Masimo Corporation
MASI
|
2.09 B | $ 137.72 | 6.07 % | $ 7.34 B | USA |
 |
Merit Medical Systems
MMSI
|
1.36 B | $ 81.8 | 0.89 % | $ 4.76 B | USA |
 |
Intuitive Surgical
ISRG
|
8.35 B | $ 547.88 | -2.48 % | $ 195 B | USA |
 |
Microbot Medical
MBOT
|
117 K | $ 2.16 | 1.89 % | $ 22 M |  Israel |
 |
Nephros
NEPH
|
14.2 M | $ 4.4 | -0.51 % | $ 45.7 M | USA |
 |
Milestone Scientific
MLSS
|
8.63 M | $ 0.29 | 0.99 % | $ 23.1 M | USA |
 |
NeuroMetrix
NURO
|
3.03 M | - | 5.05 % | $ 9.02 M | USA |
 |
OraSure Technologies
OSUR
|
186 M | $ 2.69 | 3.27 % | $ 200 M | USA |
 |
Envista Holdings Corporation
NVST
|
2.51 B | $ 24.14 | 3.92 % | $ 4.16 B | USA |
 |
Pro-Dex
PDEX
|
66.6 M | $ 40.05 | -0.72 % | $ 132 M | USA |
 |
Predictive Oncology
POAI
|
1.62 M | $ 7.28 | 1.0 % | $ 39.7 M | USA |
 |
Pulse Biosciences
PLSE
|
700 K | $ 14.3 | 1.06 % | $ 687 M | USA |
 |
Becton, Dickinson and Company
BDX
|
21.8 B | $ 207.32 | 2.88 % | $ 59.6 B | USA |
 |
Repligen Corporation
RGEN
|
632 M | $ 161.81 | -3.29 % | $ 9.02 M | USA |
 |
ResMed
RMD
|
3.58 B | $ 259.06 | 1.71 % | $ 37.8 B | USA |
 |
STERIS plc
STE
|
5.46 B | $ 264.04 | 1.58 % | $ 26 B | USA |
 |
BioLife Solutions
BLFS
|
82.3 M | $ 24.28 | 1.59 % | $ 1.12 B | USA |
 |
Stereotaxis
STXS
|
26.8 M | $ 2.76 | 2.8 % | $ 223 M | USA |
 |
Retractable Technologies
RVP
|
33 M | $ 0.72 | -2.7 % | $ 21.6 M | USA |
 |
STAAR Surgical Company
STAA
|
314 M | $ 21.52 | 1.82 % | $ 1.06 B | USA |
 |
Utah Medical Products
UTMD
|
12.3 M | $ 58.97 | 0.7 % | $ 214 M | USA |
 |
Teleflex Incorporated
TFX
|
3.05 B | $ 103.33 | -0.54 % | $ 4.84 B | USA |
 |
West Pharmaceutical Services
WST
|
2.89 B | $ 276.83 | 1.84 % | $ 20.2 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
3.79 B | $ 12.38 | 2.08 % | $ 2.52 B | USA |